Earnings Calls In Brief
This article was originally published in The Gray Sheet
Executive Summary
NuVasive: CEO Alexis Lukianov predicts that the firm will break even by the end of 2006 following a strong third quarter. During a Q3 conference call, Lukianov announced that the firm had raked in $15.1 mil. in revenue, up 48% from the prior-year period. After launching several spinal implants and instrument products during the quarter, the firm is developing a direct sales force to replace its distributors. NuVasive is now 30% represented by direct reps, up from 21% in Q2, and hopes to reach at least 80% by mid-2006. The firm filed an IDE for its NeoDisc cervical nucleus replacement device at the end of October, putting it on track for a 2010 launch (1"The Gray Sheet" Oct. 31, 2005, In Brief)...